<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - GSK</title>
<description>International Business News - GSK</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>2 drug firms to appeal $114M price fraud verdict</title>
  <description>Two large pharmaceutical companies said Thursday they will appeal a jury verdict ordering them to pay more than $114 million for overcharging the state's Medicaid program for prescription drugs.</description>
    <link>http://www.ibtimes.com/articles/20080703/glaxosmithkline-to-appeal-81m-verdict-in-ala.htm</link> 
  <pubDate>Thu, 03 Jul 2008 18:26:03 EDT</pubDate>
  </item>


  <item>
  <title>Sector Snap: Diabetes drug developers</title>
  <description>Proposals for tougher heart-risk studies on new Type 2 diabetes drugs weighed heavy on shares of Amylin Pharmaceuticals Inc. and Novo Nordisk AS Thursday, since stricter regulations could mean longer, more costly clinical trials.</description>
    <link>http://www.ibtimes.com/articles/20080703/sector-snap-diabetes-drug-developers.htm</link> 
  <pubDate>Thu, 03 Jul 2008 11:34:53 EDT</pubDate>
  </item>


  <item>
  <title>FDA lifts clinical hold on Adolor bowel drug</title>
  <description>Adolor Corp. said Thursday the Food and Drug Administration has lifted its clinical hold on the company's Entereg drug in chronically constipated patients taking opioid pain drugs.</description>
    <link>http://www.ibtimes.com/articles/20080703/fda-lifts-clinical-hold-on-adolor-bowel-drug.htm</link> 
  <pubDate>Thu, 03 Jul 2008 08:33:09 EDT</pubDate>
  </item>


  <item>
  <title>FDA panel urges more testing for diabetes drugs</title>
  <description>Diabetes drugs should face tougher safety standards that could cost manufacturers millions but protect patients from unforeseen heart risks, a government panel has recommended.</description>
    <link>http://www.ibtimes.com/articles/20080702/fda-panel-urges-more-testing-for-diabetes-drugs.htm</link> 
  <pubDate>Wed, 02 Jul 2008 17:29:02 EDT</pubDate>
  </item>


  <item>
  <title>Brown appoints new business advisers</title>
  <description>British Prime Minister Gordon Brown is appointing three top executives as new advisers on his national business council. He says Andrew Witty, chief executive of drug developer GlaxoSmithKline PLC, BT Group PLC chief executive Ian Livingston and Paul Walsh, chief executive of drinks producer Diageo PLC, will join the panel.</description>
    <link>http://www.ibtimes.com/articles/20080702/brown-appoints-new-business-advisers.htm</link> 
  <pubDate>Wed, 02 Jul 2008 12:35:45 EDT</pubDate>
  </item>


  <item>
  <title>Jury: 2 drug firms owe Ala. $114M in price fraud</title>
  <description>A state court jury on Tuesday found two major pharmaceutical companies defrauded Alabama in a long-running Medicaid drug pricing scheme and ordered the firms to pay more than $114 million in damages.</description>
    <link>http://www.ibtimes.com/articles/20080701/jury-2-drug-firms-owe-ala-114m-in-price-fraud.htm</link> 
  <pubDate>Tue, 01 Jul 2008 19:51:27 EDT</pubDate>
  </item>


  <item>
  <title>Ahead of the Bell: FDA reconsiders diabetes drugs</title>
  <description>Government regulators are reconsidering how they approve diabetes drugs. They were criticized last year for their handling of heart risks connected with a widely used GlaxoSmithKline pill.</description>
    <link>http://www.ibtimes.com/articles/20080701/ahead-of-the-bell-fda-reconsiders-diabetes-drugs.htm</link> 
  <pubDate>Tue, 01 Jul 2008 06:17:02 EDT</pubDate>
  </item>


  <item>
  <title>GlaxoSmithKline responds to FDA&amp;#39;s Cervarix query</title>
  <description>GlaxoSmithKline PLC said Monday it responded to questions raised by the Food and Drug Administration over the cervical cancer vaccine Cervarix and will provide the agency with more complete late-stage study data in 2009.</description>
    <link>http://www.ibtimes.com/articles/20080630/glaxosmithkline-responds-to-fdas-cervarix-query.htm</link> 
  <pubDate>Mon, 30 Jun 2008 11:56:05 EDT</pubDate>
  </item>


  <item>
  <title>Int&amp;#39;l business group spent $320K lobbying in 1Q</title>
  <description>The Organization for International Investment, which represents U.S. subsidiaries of foreign companies, spent $320,000 in the first quarter lobbying the federal government, according to a recent disclosure report.</description>
    <link>http://www.ibtimes.com/articles/20080627/intl-business-group-spent-320k-lobbying-in-1q.htm</link> 
  <pubDate>Fri, 27 Jun 2008 16:12:49 EDT</pubDate>
  </item>


  <item>
  <title>Exelixis, Glaxo collaboration to end in October</title>
  <description>Biopharmaceutical company Exelixis on Friday said a six-year development agreement with GlaxoSmithKline PLC will expire as scheduled at the end of October.</description>
    <link>http://www.ibtimes.com/articles/20080627/exelixis-glaxo-collaboration-to-end-in-october.htm</link> 
  <pubDate>Fri, 27 Jun 2008 07:32:06 EDT</pubDate>
  </item>


  <item>
  <title>Amgen osteoporosis drug could face FDA scrutiny</title>
  <description>Amgen&amp;#39;s experimental osteoporosis drug denosumab could have difficulty gaining Food and Drug Administration approval in its initial try, due to a higher incidence of infections compared with placebo seen in some patients, according to an osteoporosis doctor who conducted clinical trials for Amgen.</description>
    <link>http://www.ibtimes.com/articles/20080626/amgen-osteoporosis-drug-could-face-fda-scrutiny.htm</link> 
  <pubDate>Thu, 26 Jun 2008 16:59:30 EDT</pubDate>
  </item>


  <item>
  <title>Supreme Court cases could limit liability lawsuits</title>
  <description>Vermont musician Diana Levine won a $6.8 million judgment against drugmaker Wyeth after having part of her right arm amputated in 2000 when an anti-nausea drug was improperly injected.</description>
    <link>http://www.ibtimes.com/articles/20080626/supreme-court-cases-could-limit-liability-lawsuits.htm</link> 
  <pubDate>Thu, 26 Jun 2008 15:03:48 EDT</pubDate>
  </item>


  <item>
  <title>Sector Wrap: Big Pharma</title>
  <description>Pharmaceutical stocks may have ended Wednesday&amp;#39;s trading session mostly in the green, but stocks are still down substantially year to date, and a JPMorgan analyst cautioned that big pharma is no longer a strong defensive choice in a weak economy.</description>
    <link>http://www.ibtimes.com/articles/20080625/sector-wrap-big-pharma.htm</link> 
  <pubDate>Wed, 25 Jun 2008 16:47:05 EDT</pubDate>
  </item>


  <item>
  <title>Groups to buy millions of vaccines for children</title>
  <description>Millions of children and teenagers in poor countries may soon be vaccinated against seven common diseases, health officials said Wednesday. Officials at GAVI, formerly known as the Global Alliance for Vaccines and Immunization, announced they have prioritized vaccines for cervical cancer, cholera, typhoid, meningitis A, rabies, Japanese encephalitis and rubella. The vaccines will go to the world&amp;#39;s 73 poorest countries.</description>
    <link>http://www.ibtimes.com/articles/20080625/groups-to-buy-millions-of-vaccines-for-children.htm</link> 
  <pubDate>Wed, 25 Jun 2008 15:23:57 EDT</pubDate>
  </item>


  <item>
  <title>Merck slips as FDA rejects wider Gardasil use</title>
  <description>Shares of Merck &amp; Co. fell Wednesday after the Food and Drug Administration declined to expand use of the cervical cancer vaccine Gardasil to women between 27 and 45 years old.</description>
    <link>http://www.ibtimes.com/articles/20080625/merck-slips-as-fda-rejects-wider-gardasil-use.htm</link> 
  <pubDate>Wed, 25 Jun 2008 14:04:59 EDT</pubDate>
  </item>


  <item>
  <title>FDA: Merck can&amp;#39;t market Gardasil to women 27-45</title>
  <description>The drugmaker Merck &amp; Co. said Wednesday that the Food and Drug Administration has rejected expanding the use of cervical cancer vaccine Gardasil to include women ages 27 to 45.</description>
    <link>http://www.ibtimes.com/articles/20080625/fda-blocks-expanded-indication-for-mercks-gardasil.htm</link> 
  <pubDate>Wed, 25 Jun 2008 14:01:56 EDT</pubDate>
  </item>


  <item>
  <title>GlaxoSmithKline plans ads for anti-smoking aids</title>
  <description>GlaxoSmithKline says it will boost advertising of its smoking cessation products in the wake of safety concerns surrounding competitor Pfizer Inc.&amp;#39;s stop-smoking pill Chantix.</description>
    <link>http://www.ibtimes.com/articles/20080625/glaxosmithkline-plans-ads-for-anti-smoking-aids.htm</link> 
  <pubDate>Wed, 25 Jun 2008 08:15:51 EDT</pubDate>
  </item>


  <item>
  <title>FDA OKs GlaxoSmithKline kids&amp;#39; combination vaccine</title>
  <description>GlaxoSmithKline PLC said Wednesday it won Food and Drug Administration approval for a combination booster vaccine, Kinrix, which protects children ages 4 to 6 against diphtheria, tetanus, pertussis and polio with a single shot.</description>
    <link>http://www.ibtimes.com/articles/20080625/fda-oks-glaxosmithkline-kids-combination-vaccine.htm</link> 
  <pubDate>Wed, 25 Jun 2008 09:38:17 EDT</pubDate>
  </item>


  <item>
  <title>GlaxoSmithKline, Canada issue warning on HIV drug</title>
  <description>A drug used in combination with other antiretrovirals to treat HIV infection has been linked with an increased risk of heart attack, the medication&amp;#39;s manufacturer warned Monday.</description>
    <link>http://www.ibtimes.com/articles/20080623/glaxosmithkline-canada-issue-warning-on-hiv-drug.htm</link> 
  <pubDate>Mon, 23 Jun 2008 14:10:20 EDT</pubDate>
  </item>


  <item>
  <title>Ligand says FDA extends blood-clot drug review</title>
  <description>Drug developer Ligand Pharmaceuticals Inc. said after the bell Friday the Food and Drug Administration will take an additional three months to review its experimental blood-clotting drug Promacta.</description>
    <link>http://www.ibtimes.com/articles/20080620/ligand-says-fda-extends-blood-clot-drug-review.htm</link> 
  <pubDate>Fri, 20 Jun 2008 16:31:25 EDT</pubDate>
  </item>


</channel>
</rss>